Funder: National Institutes of Health (NIH)
Due Dates: Expired (Last due date: January 8, 2025)
Funding Amounts: Up to $275,000 total direct costs over 2 years, with no more than $200,000 in any single year
Summary: Supports early-stage, high-risk basic experimental research involving human participants to explore fundamental biomedical or behavioral phenomena without specific application towards products or processes.
Key Information: This FOA requires proposed studies to be basic science clinical trials involving humans and excludes studies with specific applications toward processes or products; it has been reissued as PA-25-307 effective January 8, 2025.